Mutual exclusivity analysis identifies oncogenic

Slides:



Advertisements
Similar presentations
CZ5225 Methods in Computational Biology Lecture 9: Pharmacogenetics and individual variation of drug response CZ5225 Methods in Computational Biology.
Advertisements

Molecular Systems Biology 3; Article number 140; doi: /msb
1 Harvard Medical School Mapping Transcription Mechanisms from Multimodal Genomic Data Hsun-Hsien Chang, Michael McGeachie, and Marco F. Ramoni Children.
Putting genetic interactions in context through a global modular decomposition Jamal.
Decomposition of overlapping protein complexes: A graph theoretical method for analyzing static and dynamic protein associations Algorithms for Molecular.
Data Mining Presentation Learning Patterns in the Dynamics of Biological Networks Chang hun You, Lawrence B. Holder, Diane J. Cook.
CS 548 Spring 2015 Showcase by Pankaj Didwania, Sarah Schultz, Mingchen Xie Showcasing Work by Malhotra, Chau, Sun, Hadjipanayis, & Navathe on Temporal.
Unraveling condition specific gene transcriptional regulatory networks in Saccharomyces cerevisiae Speaker: Chunhui Cai.
Complementarity of network and sequence information in homologous proteins March, Department of Computing, Imperial College London, London, UK 2.
Lecture 11. Topics in Omic Studies (Cancer Genomics, Transcriptomics and Epignomics) The Chinese University of Hong Kong CSCI5050 Bioinformatics and Computational.
CBioPortal Web resource for exploring, visualizing, and analyzing multidimentional cancer genomics data.
Case Study: Characterizing Diseased States from Expression/Regulation Data Tuck et al., BMC Bioinformatics, 2006.
Module 4: How do unrealistic expectations confound the results of our analyses Case Studies in Bioinformatics Giovanni Ciriello
Chapter 2 Genetic Variations. Introduction The human genome contains variations in base sequence from one individual to another. Some sequence variants.
CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer Max Leiserson *, Hsin-Ta Wu *, Fabio Vandin, Benjamin.
Network Analysis Goal: to turn a list of genes/proteins/metabolites into a network to capture insights about the biological system 1.Types of high-throughput.
Network applications Sushmita Roy BMI/CS 576 Dec 9 th, 2014.
Have a positive role in cell division Have a negative role in cell division Have a role in the maintenance of DNA integrity Genes altered in cancer typically:
Simultaneous identification of causal genes and dys-regulated pathways in complex diseases Yoo-Ah Kim, Stefan Wuchty and Teresa M Przytycka Paper to be.
Mining Coherent Dense Subgraphs across Multiple Biological Networks Vahid Mirjalili CSE 891.
Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data  Julia L. Williams, Peter A. Greer,
Sungkyunkwan University, School of Medicine.
1. SELECTION OF THE KEY GENE SET 2. BIOLOGICAL NETWORK SELECTION
Part 2: Genetics, monohybrid vs. Dihybrid crosses, Chi Square
This paper is about RNA can inhibit gene expression
Applications of graph theory in complex systems research
Unit 3.
Gene-set analysis Danielle Posthuma & Christiaan de Leeuw
Drugs & Genetics: Why Do Some People Respond to Drugs Differently than Others? Bilal Mohammed.
Agents of Evolutionary Change
Dept of Biomedical Informatics University of Pittsburgh
M. Fu, G. Huang, Z. Zhang, J. Liu, Z. Zhang, Z. Huang, B. Yu, F. Meng 
Genomes and Their Evolution
The cBio Cancer Genomics Portal.
University of California at San Diego
Fig. 8. Recurrent copy number amplification of BRD4 gene was observed across common cancers. Recurrent copy number amplification of BRD4 gene was observed.
A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors  Rajyalakshmi.
Strategy Description Discovery Validation Application
The Functional Impact of Alternative Splicing in Cancer
The Genomics of Cancer and Molecular Testing:
Different mode and types of inheritance
Revealing the genomic heterogeneity of melanoma
Loyola Marymount University
Mutations Mutations are changes in DNA.
Volume 27, Issue 3, Pages (March 2015)
Mutational burden of somatic, protein-altering mutations per subject from WES for patients with advanced colon cancer who participated in PD-1 blockade.
SEG5010 Presentation Zhou Lanjun.
Anastasia Baryshnikova  Cell Systems 
The Functional Impact of Alternative Splicing in Cancer
Volume 25, Issue 5, Pages e5 (October 2018)
Volume 151, Issue 2, Pages e6 (August 2016)
Bioinformatics, Vol.17 Suppl.1 (ISMB 2001) Weekly Lab. Seminar
Pan-Cancer Analysis of Mutation Hotspots in Protein Domains
Volume 25, Issue 13, Pages e6 (December 2018)
Volume 29, Issue 5, Pages (May 2016)
Loyola Marymount University
Genes and Inheritance.
BIOBASE Training TRANSFAC® ExPlain™
Landscape of genomic alterations in 444 tumors from 429 patients with mCRPC. Landscape of genomic alterations in 444 tumors from 429 patients with mCRPC.
Signature A and B MEFs exhibit differential metabolic and proliferation phenotype strengths Signature A and B MEFs exhibit differential metabolic and proliferation.
Loyola Marymount University
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours By: Anh Pham.
Loyola Marymount University
Targetable alterations and pathways in TNBCs after NAC
Concordance between the genomic landscape identified by whole-exome sequencing of plasma cfDNA and tumor; DNA and recurrence of KDR/VEGFR2 oncogenic mutations.
Landscape of genomic alterations identified by WES in biopsies of patients with advanced PDAC. Co-mutation plot displaying integrated genomic data for.
Global analysis of the chemical–genetic interaction map.
The ovarian cancer cell lines modestly recapitulate the spectrum of mutations found in primary ovarian tumors. The ovarian cancer cell lines modestly recapitulate.
Genomic instability is a core feature of ovarian cancer that frequently involves DNA-damage repair genes. Genomic instability is a core feature of ovarian.
Volume 28, Issue 4, Pages e6 (July 2019)
Presentation transcript:

Mutual exclusivity analysis identifies oncogenic network modules Giovanni Ciriello,1,3,4 Ethan Cerami,1,2,3 Chris Sander,1 and Nikolaus Schultz1

Background Motivation Method Result

Background Pathway Smallest functional unit of a network of proteins that interacts to performs a single task.

Background Network Union of all pathways

Motivation Basic motivation: to identify oncogenic pathway modules.

Why Mutual exclusivity analysis? Many oncogenic events effect a limited number of biological pathways Mutually exclusive genomic alteration observed

Example P53 VS MDM2

Goal of MEMo Identify sets of connected genes that are recurrently altered, likely belongs to the same pathway or biological process, and exhibit patterns of mutually exclusive generic alteration across multiple patients.

Method

Step 1: Build Binary Event Matrix of Significant Altered Genes The first filter identifies genes that are mutated significantly above the background mutation rate (BMR). The second filter identifies genes that are targets of recurrent copy number amplification or deletion. The third filter identifies copy number altered genes that have concordant mRNA expression

Note Genes that does not have a concordant mRNA expression would not likely to change the pathway function and therefore unlikely to be drivers. The binary matrix built does not take into account for the multiply mutation within a gene/case, nor does it not account for varying allelic frequency

Step 2: Identifying all gene pairs likely to be involved in the same pathway

Step 3: Build graph of gene pairs and extract clique

Similarity metric between genes Javg is 4% to 7% for known gene pairs that have similar functions

Connecting similar genes If a pair of genes has a high J value, marked them as functional similar and connect them.

Clique extraction

Non informative clique deletion A clique is said to be informative if number of times the corresponding gene is altered concurrently with other genes in the clique is smaller than the number of unique alterations

Step 4: Mutual exclusivity test

Result